Prelude Capital Management’s CVS Health CVS Stock Holding History

Prelude Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,500	Closed	-$1.08M	–	1905
2021 Q4	$1.08M	Buy	10,500 +100	+1%	+$9.24K	0.03%	565
2021 Q3	$883K	Hold	10,400	–	–	0.02%	616
2021 Q2	$868K	Sell	10,400 -39,600	-79%	-$3.24M	0.03%	690
2021 Q1	$3.76M	Sell	50,000 -20,600	-29%	-$1.5M	0.1%	147
2020 Q4	$4.82M	Buy	+70,600	New	+$4.59M	0.12%	111
2020 Q3	–	Sell	-40,300	Closed	-$2.62M	–	1918
2020 Q2	$2.62M	Hold	40,300	–	–	0.14%	119
2020 Q1	$2.39M	Buy	40,300 +300	+0.8%	+$20K	0.16%	85
2019 Q4	$2.97M	Hold	40,000	–	–	0.11%	119
2019 Q3	$2.52M	Hold	40,000	–	–	0.11%	141
2019 Q2	$2.18M	Sell	40,000 -5,800	-13%	-$312K	0.11%	176
2019 Q1	$2.47M	Buy	+45,800	New	+$2.83M	0.14%	142
2017 Q4	–	Sell	-17,900	Closed	-$1.46M	–	1419
2017 Q3	$1.46M	Buy	+17,900	New	+$1.42M	0.13%	167

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prelude Capital Management's CVS Position: Q1 2026 in Review

Prelude Capital Management increased its CVS Health (CVS) stake by 339% in Q1 2026, buying an estimated $685K and bringing the position to 11,518 shares worth $827K. The position accounts for 0.06% of the portfolio, ranked #349.

Prelude Capital Management first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $4.1M in Q1 2022. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Prelude Capital Management held 11,518 shares of CVS Health worth $827K as of Q1 2026.
Prelude Capital Management bought 8,895 CVS Health shares in Q1 2026, an estimated $685K.
CVS Health made up 0.06% of Prelude Capital Management's portfolio in Q1 2026, its #349 holding.
Prelude Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
Prelude Capital Management's CVS Health position peaked at $4.1M in Q1 2022.
1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.